Grape King Bio Ltd
TWSE:1707
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
133.5
162
|
Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Grape King Bio Ltd stock under the Base Case scenario is 202.16 TWD. Compared to the current market price of 151 TWD, Grape King Bio Ltd is Undervalued by 25%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Grape King Bio Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Grape King Bio Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Grape King Bio Ltd
Balance Sheet Decomposition
Grape King Bio Ltd
Current Assets | 5.4B |
Cash & Short-Term Investments | 4.2B |
Receivables | 335.8m |
Other Current Assets | 842.5m |
Non-Current Assets | 9.7B |
Long-Term Investments | 1.6B |
PP&E | 8B |
Intangibles | 119.8m |
Other Non-Current Assets | 57.3m |
Current Liabilities | 3.9B |
Accounts Payable | 389.4m |
Accrued Liabilities | 1.8B |
Other Current Liabilities | 1.8B |
Non-Current Liabilities | 1.5B |
Long-Term Debt | 125.9m |
Other Non-Current Liabilities | 1.4B |
Earnings Waterfall
Grape King Bio Ltd
Revenue
|
10.9B
TWD
|
Cost of Revenue
|
-2.4B
TWD
|
Gross Profit
|
8.5B
TWD
|
Operating Expenses
|
-6B
TWD
|
Operating Income
|
2.4B
TWD
|
Other Expenses
|
-1B
TWD
|
Net Income
|
1.4B
TWD
|
Free Cash Flow Analysis
Grape King Bio Ltd
TWD | |
Free Cash Flow | TWD |
Profitability Score
Profitability Due Diligence
Grape King Bio Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
Score
Grape King Bio Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Grape King Bio Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Score
Grape King Bio Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Grape King Bio Ltd
According to Wall Street analysts, the average 1-year price target for Grape King Bio Ltd is 171.87 TWD with a low forecast of 167.66 TWD and a high forecast of 179.55 TWD.
Dividends
Current shareholder yield for Grape King Bio Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Grape King Bio Ltd. engages in the production and sale of pharmaceutical preparations, patent medicine, liquid tonics, drinks, and healthy food. The company is headquartered in Taoyuan, Taoyuan. The firm operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The firm operates in Taiwan, mainland China and other markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Grape King Bio Ltd stock under the Base Case scenario is 202.16 TWD.
Compared to the current market price of 151 TWD, Grape King Bio Ltd is Undervalued by 25%.